SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,696,035 | -77.0% | 2,813,543 | -53.7% | 0.00% | -77.8% |
Q2 2023 | $29,084,348 | -54.6% | 6,072,942 | -46.3% | 0.02% | -57.1% |
Q1 2023 | $64,063,666 | +1.7% | 11,300,815 | +0.5% | 0.04% | -6.7% |
Q4 2022 | $63,001,442 | -12.2% | 11,248,292 | -49.6% | 0.04% | -16.7% |
Q3 2022 | $71,756,685 | +289.6% | 22,326,496 | +315.7% | 0.05% | +315.4% |
Q2 2022 | $18,419,000 | -55.5% | 5,370,409 | -7.5% | 0.01% | -35.0% |
Q1 2022 | $41,348,000 | -1.8% | 5,806,680 | +14.9% | 0.02% | +11.1% |
Q4 2021 | $42,110,000 | +39.5% | 5,055,099 | +16.5% | 0.02% | +38.5% |
Q3 2021 | $30,197,000 | -66.7% | 4,338,801 | +14.0% | 0.01% | -66.7% |
Q2 2021 | $90,771,000 | +20.8% | 3,805,739 | +4.3% | 0.04% | +14.7% |
Q1 2021 | $75,116,000 | +15.9% | 3,647,933 | +37.9% | 0.03% | +13.3% |
Q4 2020 | $64,810,000 | +19.6% | 2,645,274 | +38.2% | 0.03% | +7.1% |
Q3 2020 | $54,185,000 | – | 1,914,077 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
Knott David M Jr | 70,000 | $167 | 0.06% |
XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |